● Kodiak Sciences (KOD) closed at $89.92 on Monday, up about 178% from $32.35, after positive Phase 3 DAYBREAK results.
● Kodiak Sciences (KOD) closed at $89.92 on Monday, up about 178%, after Zenkuda data on longer dosing intervals.
● Kodiak Sciences (KOD) closed at $89.92 on Monday, about 178% above Friday's $32.35, after positive DAYBREAK data.
● Lifecore Biomedical (LFCR) closed at $6.52 on Monday, about 24 cents above the $6.28 cash price offered by Webster.
● Liquidia (LQDA) closed at $73.67 on Monday, up about 7.7% from $68.43, while most of the market fell.
● MBX Biosciences (MBX) closed at $57.54 on Monday, up 7.3% from $53.63, while all three major indexes ended lower.
● Agenus (AGEN) closed at $9.43 on Monday, up 10.4% from $8.54, after Rodman & Renshaw began coverage at Buy.
● Acadia Healthcare (ACHC) closed at $27.91 on Monday, down 0.64% from $28.09, after Raymond James lowered its rating.
Shares of Teleflex (NYSE:TFX) ended Monday, September 28, 2026 higher by 4.35%, at $127.38. The company is a medical-device maker producing single-use and specialty devices used across hospitals and other care settings.
PTC Therapeutics (NASDAQ:PTCT) was among the gainers in US markets on Monday, September 28, 2026, closing the session up 5.23% at $65.95. The biopharmaceutical company develops and commercializes treatments for rare disorders, with commercial products and a pipeline.